Thirty Madison Stock
Thirty Madison is a family of specialized healthcare brands creating exceptional outcomes for all.
Sign up today and learn more about Thirty Madison Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Thirty Madison Stock
Thirty Madison is a family of specialized healthcare brands devoted to creating exceptional outcomes for all. Each of its specialized brands is focused on a specific ongoing condition, and thoughtfully designed to support the unique needs of its community with personalized treatments and care; with Keeps for men's hair loss, Cove for migraine, Picnic for allergies, Facet for skin conditions, and NURX for sexual health. With empathy at the heart of its innovation, its proprietary care model empowers hundreds of thousands of people with ongoing conditions with the accessible, effective treatments across a lifetime of care. Learn more at ThirtyMadison.com.
Investors
HealthQuest Capital
Polaris Partners
Freenome, Automattic, Club Factory, Thirty Madison, OM1, Egnyte, Quartet, Impinj, VeraCode, Xant
Funding History
November 2017 | $7.5M |
---|---|
October 2018 | $15.3M |
August 2020 | $47.0M |
June 2021 | $140M |
Management
Co-Founder
Demetri Karagas
Co-Founder and CEO
Steven Gutentag
GM, Picnic (picnicallergy.com)
Alexis Tarlow
CTOCTO Thirty Madison
Matthew Mengerink
Associate Director, Strategy & Operations
Chelsea Orcutt
Board Member
Amy Schulman
Board Member
Jason Stoffer
Board Member
Randy Scott
Staff Software Engineer
Karl Carstensen
CISO
Justin Berman
Interim Head of People
Chelsea Kocis
Press
linkedin - Apr, 6 2024
Commercial Observer on LinkedIn: Health Care Service Thirty Madison Signs 15K-SF Lease at 183 Madison Avenuebuiltinnyc - Apr, 6 2024
Growth Partnerships Associate - Thirty Madisoncrainsnewyork - Apr, 6 2024
Telehealth unicorn inks lease on Madison Avenueprnewswire - Jan, 17 2024
Thirty Madison welcomes Nirveek De as its Chief Product Officer to drive continued expansion, innovation in specialty caredermatologytimes - Dec, 19 2023
The Power of the Microbiome in Inflammatory Skin Diseases